EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+26.68%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.34B
AUM Growth
+$1.34B
(+31%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
6.14%
Top 10 Holdings %
Top 10 Hldgs %
62.68%
Holding
74
New
17
Increased
20
Reduced
29
Closed
4
Top Buys
| 1 |
GSK
GSK
|
$34.3M |
| 2 |
Revvity
RVTY
|
$31.5M |
| 3 |
Pfizer
PFE
|
$30.6M |
| 4 |
Viatris
VTRS
|
$15.7M |
| 5 |
Inspire Medical Systems
INSP
|
$14.9M |
Top Sells
| 1 |
Natera
NTRA
|
$43.3M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$22.2M |
| 3 |
argenx
ARGX
|
$12.3M |
| 4 |
Illumina
ILMN
|
$12.1M |
| 5 |
Krystal Biotech
KRYS
|
$11.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $163M | 10.85% | 1,778,051 -473,537 | -21% | -$43.3M |
|
|
2
GSK
GSK
$79.9B
| $162M | 10.79% | 3,771,994 +799,040 | +27% | +$34.3M |
|
|
3
Inspire Medical Systems
INSP
$2.77B
| $90.4M | 6.03% | 420,699 +69,583 | +20% | +$14.9M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $85M | 5.67% | 6,025,169 -129,185 | -2% | -$1.82M |
|
5
Vera Therapeutics
VERA
$1.38B
| $78.6M | 5.25% | 1,823,781 -91,049 | -5% | -$3.93M |
|
6
Syndax Pharmaceuticals
SNDX
$1.41B
| $74.6M | 4.97% | 3,133,113 -250,131 | -7% | -$5.95M |
|
7
United Therapeutics
UTHR
$13.8B
| $57.7M | 3.85% | 251,135 +4,901 | +2% | +$1.13M |
|
|
8
Revvity
RVTY
$10.5B
| $50.7M | 3.38% | 483,160 +300,101 | +164% | +$31.5M |
|
9
Bio-Techne
TECH
$8.5B
| $42.8M | 2.85% | 607,687 +142,380 | +31% | +$10M |
|
10
HCA Healthcare
HCA
$94.5B
| $34.6M | 2.31% | 103,821 -10,984 | -10% | -$3.66M |
|
11
HealthEquity
HQY
$7.72B
| $34.4M | 2.29% | 421,345 -73,574 | -15% | -$6.01M |
|
|
12
Pfizer
PFE
$141B
| $30.6M | 2.04% | +1,102,042 | New | +$30.6M |
|
13
Celldex Therapeutics
CLDX
$1.47B
| $29.8M | 1.99% | 711,115 -42,992 | -6% | -$1.8M |
|
14
Community Health Systems
CYH
$387M
| $27.9M | 1.86% | 7,980,641 +749,515 | +10% | +$2.62M |
|
|
SWAV
15
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $26.2M | 1.75% | 80,555 +4,733 | +6% | +$1.54M |
|
|
16
argenx
ARGX
$43.6B
| $21.5M | 1.43% | 54,518 -31,314 | -36% | -$12.3M |
|
17
Tenet Healthcare
THC
$16.3B
| $18.5M | 1.23% | 175,631 -11,634 | -6% | -$1.22M |
|
18
Ionis Pharmaceuticals
IONS
$6.79B
| $16.3M | 1.09% | 376,438 +51,784 | +16% | +$2.24M |
|
|
19
Viatris
VTRS
$12.3B
| $15.7M | 1.05% | +1,316,469 | New | +$15.7M |
|
20
Vaxcyte
PCVX
$4B
| $13.5M | 0.9% | 197,331 -36,508 | -16% | -$2.49M |
|
21
Humana
HUM
$36.5B
| $12.3M | 0.82% | 35,532 +33,618 | +1,756% | +$11.7M |
|
22
Protagonist Therapeutics
PTGX
$3.67B
| $11.9M | 0.79% | 411,478 -126,596 | -24% | -$3.66M |
|
|
TARO
23
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $11.2M | 0.74% | 263,541 +7,553 | +3% | +$320K |
|
24
MannKind Corp
MNKD
$1.41B
| $10.8M | 0.72% | +2,391,128 | New | +$10.8M |
|
25
Danaher
DHR
$147B
| $10.2M | 0.68% | 40,855 -186 | -0.5% | -$46.4K |
|